| Nature of Business and Significant Accounting Policies - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2019 | Dec. 31, 2018 | 
|---|---|---|
| Accounting Policies [Abstract] | ||
| Indemnification assets | $ 875 | |
| Lab supply inventory | 1,825 | |
| Prepaid assets | 971 | 1,230 | 
| Funds in escrow | 888 | |
| Other | 167 | 65 | 
| Total other current assets | $ 3,851 | $ 2,170 | 
| X | ||||||||||
| 
- Definition Funds in escrow. No definition available. 
 | 
| X | ||||||||||
| 
- References No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Amount of assets classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Amount of current assets classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition The amount for the individual regulatory asset as itemized in a table of regulatory assets as of the end of the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 |